US6008217A
(en)
*
|
1995-12-20 |
1999-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US5874424A
(en)
*
|
1995-12-20 |
1999-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
US6995141B1
(en)
|
1990-04-04 |
2006-02-07 |
Vertex Pharmaceuticals Incorporated |
Interleukin 1β protease and interleukin 1β protease inhibitors
|
CA2071674C
(en)
*
|
1991-06-21 |
2003-08-19 |
Kevin T. Chapman |
Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme
|
US6348570B1
(en)
|
1991-08-16 |
2002-02-19 |
Merck & Co., Inc. |
Chromophore containing compounds and their use in determining interleukin-1β convertase activity
|
DE69229252T2
(en)
*
|
1991-08-16 |
1999-12-16 |
Merck & Co Inc |
DNA encoding the interleukin-1B precursor converting enzyme
|
HU220098B
(en)
*
|
1991-08-30 |
2001-10-28 |
Vertex Pharmaceuticals Incorporated |
Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
|
GB9123326D0
(en)
*
|
1991-11-04 |
1991-12-18 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
AU3479593A
(en)
*
|
1992-01-31 |
1993-09-01 |
Merck & Co., Inc. |
Peptidyl derivatives as inhibitors of interleukin-1beta converting enzyme
|
EP0627926B1
(en)
*
|
1992-02-21 |
1998-08-05 |
Merck & Co., Inc. (a New Jersey corp.) |
PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
|
US6939850B2
(en)
|
1992-06-12 |
2005-09-06 |
Massachusetts Institute Of Technology |
Altered human interleukin-1β convertase (ICE), NEDD-2, and C. elegans ced-3 polypeptides and uses therefor
|
US5962301A
(en)
*
|
1992-06-12 |
1999-10-05 |
Massachusetts Institute Of Technology |
Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
|
EP0672151A1
(en)
*
|
1992-06-12 |
1995-09-20 |
Massachusetts Institute Of Technology |
Inhibitors of ced-3 and related proteins
|
CA2139854A1
(en)
*
|
1992-07-31 |
1994-02-17 |
Ralph P. Robinson |
Peptidyl 4-amino-2, 2-difluoro-3-oxo-1, 6-hexanedioic acid derivatives as antiinflammatory agents
|
EP0618223A3
(en)
*
|
1993-03-08 |
1996-06-12 |
Sandoz Ltd |
Peptides inhibiting interleukin 1-bêta release useful as antiinflammatory agents.
|
CA2122227A1
(en)
*
|
1993-04-29 |
1994-10-30 |
Roland E. Dolle |
Peptide analogs as irreversible interleukin-1.beta. protease inhibitors
|
US5985838A
(en)
|
1993-04-29 |
1999-11-16 |
Vertex Pharmaceuticals, Inc. |
Peptide analogs as irreversible interleukin-1β protease inhibitors
|
US5462939A
(en)
*
|
1993-05-07 |
1995-10-31 |
Sterling Winthrop Inc. |
Peptidic ketones as interleukin-1β-converting enzyme inhibitors
|
JPH0789951A
(en)
*
|
1993-06-03 |
1995-04-04 |
Sterling Winthrop Inc |
Interleukin-1 beta transfer enzyme inhibitor
|
US5843905A
(en)
*
|
1993-06-04 |
1998-12-01 |
Vertex Pharmaceuticals, Incorporated |
Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors
|
ATE163412T1
(en)
|
1993-06-08 |
1998-03-15 |
Sanofi Sa |
PYRIDAZINE AS INTERLEUKIN-1-BETA CONVERSION ENZYME INHIBITORS
|
EP0711174A4
(en)
*
|
1993-06-24 |
1997-11-12 |
Gen Hospital Corp |
Programmed cell death genes and proteins
|
US6087160A
(en)
*
|
1993-06-24 |
2000-07-11 |
The General Hospital Corporation |
Programmed cell death genes and proteins
|
US5866545A
(en)
*
|
1993-08-13 |
1999-02-02 |
Merck & Co., Inc. |
Substituted ketone derivatives as inhibitors of interleukin-1β converting enzyme
|
US6420522B1
(en)
|
1995-06-05 |
2002-07-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US5756466A
(en)
*
|
1994-06-17 |
1998-05-26 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
US5847135A
(en)
*
|
1994-06-17 |
1998-12-08 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US5716929A
(en)
*
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
WO1996000297A1
(en)
*
|
1994-06-23 |
1996-01-04 |
Human Genome Sciences, Inc. |
INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2
|
CA2202549C
(en)
*
|
1994-10-14 |
2003-08-05 |
Tara Seshadri |
Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
|
US5856169A
(en)
*
|
1995-02-21 |
1999-01-05 |
Thomas Jefferson University |
Isoforms of human interleukin-1β converting enzyme and methods of using the same
|
US5798442A
(en)
*
|
1995-04-21 |
1998-08-25 |
Merck Frosst Canada, Inc. |
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
|
US5869315A
(en)
|
1995-12-18 |
1999-02-09 |
Basf Aktiengesellschaft |
Modified interleukin-1β converting enzyme with increased stability
|
US5843904A
(en)
*
|
1995-12-20 |
1998-12-01 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1βconverting enzyme
|
US6288037B1
(en)
|
1996-01-29 |
2001-09-11 |
Basf Aktiengesellschaft |
Substrates and inhibitors for cysteine protease ICH-1
|
US6531467B2
(en)
|
1996-09-12 |
2003-03-11 |
Idun Pharmaceuticals, Inc. |
Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
US6200969B1
(en)
|
1996-09-12 |
2001-03-13 |
Idun Pharmaceuticals, Inc. |
Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
US6610683B2
(en)
|
1996-09-12 |
2003-08-26 |
Idun Pharmaceuticals, Inc. |
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
CN1138472C
(en)
*
|
1997-10-10 |
2004-02-18 |
西托维亚公司 |
Dipeptide apoptosis inhibitors and the use thereof
|
US6184210B1
(en)
|
1997-10-10 |
2001-02-06 |
Cytovia, Inc. |
Dipeptide apoptosis inhibitors and the use thereof
|
WO1999046248A1
(en)
|
1998-03-09 |
1999-09-16 |
Vertex Pharmaceuticals Incorporated |
1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
|
DE69939689D1
(en)
|
1998-03-19 |
2008-11-20 |
Vertex Pharma |
CASPASE INHIBITORS
|
EP1923386A3
(en)
|
2000-03-29 |
2008-05-28 |
Vertex Pharmceuticals Incorporated |
Carbamate caspase inhibitors and uses thereof
|
CN1994298A
(en)
|
2000-03-29 |
2007-07-11 |
沃泰克斯药物股份有限公司 |
Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof
|
EP2241328A1
(en)
|
2000-05-12 |
2010-10-20 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
PE20011350A1
(en)
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE)
|
WO2001090070A2
(en)
|
2000-05-23 |
2001-11-29 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
EP2295054A1
(en)
|
2004-05-27 |
2011-03-16 |
Vertex Pharmaceuticals Incorporated |
Ice inhibitors for the treatment of autoinflammatory diseases
|
US20140309172A1
(en)
|
2010-11-05 |
2014-10-16 |
Dagmar Ringe |
Ice inhibiting compounds and uses thereof
|